Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

Meghan Trainor showed off her new body in a two-piece set at iHeartRadio's 102.7 KIIS FM Wango Tango in May 2025 after ...

Research shows that drinking water can influence your appetite, metabolism, and overall calorie intake. Your water needs ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Christopher Schwarzenegger opened up about his dramatic weight loss transformation at the Inaugural Beacher Vitality Happy & ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

The National Institute for Health and Care Excellence (Nice) previously stopped its appraisal of semaglutide (Wegovy) for use ...